---
topic: "red-yeast-rice"
period: "2026-02"
generated_at: "2026-02-21T19:47:44.384365+00:00"
total_articles: 172
---

# 紅麴文獻薈萃報告 — 2026 年 2 月

## 摘要

本月共收錄 紅麴 相關文獻 172 篇，其中 Level 1 證據（Meta-Analysis/Systematic Review）11 篇，RCT 11 篇。

## 證據等級分布

| 證據等級 | 文獻數 | 佔比 |
|----------|--------|------|
| Level 1 (Meta-Analysis/Systematic Review) | 11 | 6.4% |
| Level 2 (RCT) | 11 | 6.4% |
| Level 3 (Clinical Trial) | 2 | 1.2% |
| Level 4 (Observational) | 1 | 0.6% |
| Level 5 (Review/Case Report/Other) | 147 | 85.5% |

## 功效分類統計

| 功效分類 | 中文 | 文獻數 | 佔比 |
|----------|------|--------|------|
| cardiovascular | 心血管 | 155 | 90.1% |
| metabolic | 代謝 | 44 | 25.6% |
| immune | 免疫調節 | 20 | 11.6% |
| digestive | 消化 | 15 | 8.7% |
| musculoskeletal | 肌肉骨骼 | 14 | 8.1% |
| other | 其他 | 14 | 8.1% |
| anti_aging | 抗衰老 | 8 | 4.7% |
| energy | 活力 | 4 | 2.3% |
| cognitive | 認知功能 | 2 | 1.2% |
| sexual | 性功能 | 1 | 0.6% |

## 成分搭配統計

| 成分 | 文獻數 |
|------|--------|
| NAC | 68 |
| EPA | 36 |
| berberine | 18 |
| garlic | 8 |
| coenzyme Q10 | 5 |
| fiber | 5 |
| creatine | 4 |
| omega-3 | 4 |
| astaxanthin | 3 |
| glutathione | 3 |

## 成分組合分析

以下列出最常被共同研究的成分組合：

| 成分組合 | 共同出現文獻數 |
|----------|---------------|
| EPA + NAC | 19 |
| NAC + berberine | 6 |
| berberine + garlic | 5 |
| berberine + fiber | 4 |
| NAC + glutathione | 3 |
| NAC + coenzyme Q10 | 3 |
| fiber + garlic | 3 |
| berberine + green tea | 3 |
| garlic + green tea | 3 |
| cinnamon + garlic | 3 |

## 成分功效分析

以下列出主要成分在各功效領域的研究文獻數：

| 成分 | 總文獻 | 心血管 | 代謝 | 免疫調節 | 消化 | 肌肉骨骼 | 抗衰老 |
|------|--------|--------|--------|--------|--------|--------|--------|
| NAC | 68 | 62 | 9 | 9 | 5 | 6 | 2 |
| EPA | 36 | 36 | 12 | 6 | 5 | 4 | 2 |
| berberine | 18 | 18 | 6 | - | 2 | 2 | 1 |
| garlic | 8 | 8 | 1 | 1 | 1 | 1 | 1 |
| coenzyme Q10 | 5 | 4 | 1 | 1 | - | - | - |
| fiber | 5 | 5 | 1 | - | 2 | - | 1 |

## 研究類型分布

| 研究類型 | 文獻數 | 佔比 |
|----------|--------|------|
| Meta-Analysis | 9 | 5.2% |
| Systematic Review | 2 | 1.2% |
| RCT | 11 | 6.4% |
| Clinical Trial | 2 | 1.2% |
| Observational | 1 | 0.6% |
| Review | 26 | 15.1% |
| Case Report | 11 | 6.4% |
| Other | 110 | 64.0% |

## 近期重要文獻

### Level 1 證據（Meta-Analysis / Systematic Review）

1. **[Effectiveness of red yeast rice on carotid atherosclerosis: A systematic review and meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/36120360/)** — Frontiers in pharmacology, 2022-01-01
   - 功效分類：cardiovascular

2. **[Effects of the combination of red yeast rice-containing commercial Chinese polyherbal preparation with statins for dyslipidemia: a systematic review and meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/39108747/)** — Frontiers in pharmacology, 2024-01-01
   - 功效分類：cardiovascular

3. **[A network meta-analysis on the comparative effect of nutraceuticals on lipid profile in adults.](https://pubmed.ncbi.nlm.nih.gov/35988871/)** — Pharmacological research, 2022-09-01
   - 功效分類：cardiovascular, musculoskeletal

4. **[Comparing the effectiveness of Chinese patent medicines containing red yeast rice on hyperlipidaemia: A network meta-analysis of randomized controlled trials.](https://pubmed.ncbi.nlm.nih.gov/34762365/)** — Endocrinology, diabetes & metabolism, 2022-01-01
   - 功效分類：cardiovascular

5. **[Monacolin K supplementation in patients with hypercholesterolemia: A systematic review of clinical trials.](https://pubmed.ncbi.nlm.nih.gov/38310834/)** — Semergen, 2024-01-01
   - 功效分類：cardiovascular


### Level 2 證據（RCT）

1. **[Efficacy of AI-Guided (GenAIS](https://pubmed.ncbi.nlm.nih.gov/38999770/)** — Nutrients, 2024-06-26
   - 功效分類：cardiovascular, metabolic

2. **[Dual modulation of lipid and glucose metabolism by a nutraceutical combination in patients at cardiometabolic risk: results from a multicenter randomized controlled trial.](https://pubmed.ncbi.nlm.nih.gov/41044582/)** — Cardiovascular diabetology, 2025-10-03
   - 功效分類：cardiovascular, metabolic

3. **[Low dose red yeast rice with monacolin K lowers LDL cholesterol and blood pressure in Japanese with mild dyslipidemia: A multicenter, randomized trial.](https://pubmed.ncbi.nlm.nih.gov/34587702/)** — Asia Pacific journal of clinical nutrition, 2021-09-01
   - 功效分類：cardiovascular, musculoskeletal

4. **[Efficacy of Food Supplement Based on Monacolins, γ-Oryzanol, and γ-Aminobutyric Acid in Mild Dyslipidemia: A Randomized, Double-Blind, Parallel-Armed, Placebo-Controlled Clinical Trial.](https://pubmed.ncbi.nlm.nih.gov/39275298/)** — Nutrients, 2024-09-04
   - 功效分類：cardiovascular

5. **[Randomized, Double-Blind, Placebo-Controlled Trial to Test the Effects of a Nutraceutical Combination Monacolin K-Free on the Lipid and Inflammatory Profile of Subjects with Hypercholesterolemia.](https://pubmed.ncbi.nlm.nih.gov/35889769/)** — Nutrients, 2022-07-08
   - 功效分類：cardiovascular, immune

